








The relationship between Stigma and Self-Efficacy in individuals with epilepsy 






A thesis submitted in partial fulfilment of the requirements for the degree of 
Doctor of Clinical Psychology 
 
 
The University of Sheffield 
Faculty of Science 




































































I declare that this work has not been submitted for any other degree at the University 























Literature Review      7,881 
Including references and tables    10,990 
 
Research Report      7,533 
Including references and tables    10,419 
 
Total        15, 414 

















Firstly I would like to thank both of my supervisors for their advice and feedback. I 
am thankful to FND Action and Epilepsy Action for their help and support with the study. I 
am very thankful to all of the participants who took part in the study, giving up their time. I 
learnt so much from working with you. I am grateful to Dr Jo Varela for her incredible 
support and Dr Claire Bone for her ceaseless good humour. I would also like to thank the ITU 
staff at QEQM, without them, none of this would have been possible. Finally, I would like to 
thank my family, in particular my girlfriend, my mother and grandmother for their support 


















Stigma is when a certain characteristic (such as weight or race) causes an individual 
or group to be treated negatively based on a feature that differentiates them from other 
members of society. Stigma can be considered in different ways; Stigma can be ‘enacted’, 
when the individual is directly discriminated against, and ‘perceived’, when individual 
believes the negative actions of others to be linked to an undesirable characteristic of their 
self. Stigma can have serious consequences, such as reduced quality of life, lower rates of 
employment and less overall life satisfaction.  
Epilepsy is a reasonably common neurological disorder where individuals experience 
seizures. Over 500,000 UK residents are estimated to be affected by Epilepsy. It can be 
caused by a number of different factors, such as brain lesions, but there may be no known 
cause for up to two-thirds of individuals with epilepsy. Historically, seizures have been 
associated with negative factors, such as demonic possession, and have experienced stigma. 
There is also evidence that stigmatising attitudes towards seizures continue to be prevalent.       
 Non-epileptic attack disorder (NEAD) is a condition whereby an individual 
experiences seizures that are outwardly similar to epileptic seizures. These seizures, however, 
are not associated with the neurological correlates of epilepsy. NEAD is a fairly common 
disorder with an estimated 15 000 UK residents receiving a diagnosis. The causes of NEAD 
are often considered psychological rather than physical and, as such, NEAD is often 
considered a mental health disorder.  
The causes and manifestations of stigma in NEAD are unclear. This project aimed to 
extend the current understanding of stigma in NEAD by first: reviewing the literature on the 
experiences of stigma for NEAD and second: investigating the possible underlying factors 





Part I describes the outcomes of a systematic narrative review that identified 22 
papers investigating the experiences of stigma by individuals diagnosed with NEAD. The 
results indicate that individuals with NEAD experience stigma from healthcare professionals, 
the public, and family and friends. Some evidence suggests that individuals with NEAD 
experience higher rates of stigma than epilepsy.  
Part II presents a cross-sectional study that investigate the relationship between 
perceived stigma and self-efficacy, depression, anxiety and seizure symptom severity in 2 
groups (epilepsy and NEAD). The study found individuals with NEAD report more perceived 
stigma than those with epilepsy and higher, clinical, levels of depression. The severity of 
symptoms was not associated with perceived stigma for NEAD but it was with epilepsy. 
Depression was significant predictive factor for perceived stigma in both epilepsy and 
NEAD. 
These studies develop the current understanding of stigma in NEAD and epilepsy. 
The findings suggest individuals with NEAD experience more stigma than those with 
Epilepsy and that depression predicts perceived stigma for other groups. The findings also 
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Part I: Literature Review  

















To systematically explore the experiences of stigma from the perspective of 
individuals with Non-epileptic Attack Disorder (NEAD) and healthcare professionals 
involved in their care.  
Method 
A systematic narrative review of the literature was undertaken. Databases were 
searched by title, abstract and key terms. Searches were completed in MEDLINE, CINAHL, 
PsycINFO, SCOPUS, Web of Science and Google Scholar. The search was completed in 
July, 2019 
Results 
In total 22 papers were included in the final review. Experiences of stigma from the 
perspective of individuals with NEAD were found to be present in the literature. Where 
comparisons were made, individuals with NEAD reported higher levels of stigma than a 
comparable disorder (epilepsy). One paper suggested a possible treatment interventions for 
stigma in NEAD 
There is emerging evidence for the considering importance of stigma in NEAD 
Further longitudinal research, however, would be beneficial.   
Practitioner points 
• Professionals should consider if their attitudes and terminology towards NEAD 





• It could be beneficial to consider interventions targeting stigma in NEAD Focused 
Expressive Writing may be a useful intervention.  
Limitations 
• Many of the conclusions of the quantitative studies are largely based on 
correlational data from cross-sectional study. This limits our understanding of the 
causes of stigma in NEAD 
• There is limited direct evidence of negative and stigmatising public attitudes 
towards NEAD, despite professionals and individuals with NEAD stating it as an 

















   Introduction 
Stigma is a process that can be defined as occurring when a specific characteristic of 
an individual is or appears to be devalued by others.  It is often associated with thoughts of 
inadequacy, being rejected, and with feelings of shame and humiliation (Goffman, 1963; 
Link & Phelan, 2001). Existing research has examined stigma associated with a range of 
different conditions, including the quality of life in long term cancer patients (Johnson et al., 
2019), the physical and psychological impact of limb amputation (Robert, 2019), and the 
visible appearance of skin conditions (Thompson et al., 2010), and help seeking behaviour of 
individuals with mental health disorders (Durna, Yorulmaz, & Aktac, 2019).  
Goffman (1963) defined stigma as process by which a specific attribute of an 
individual is caused to be ‘…reduced in our minds from a whole and usual person to a 
tainted, discounted one.’ (pg. 3). Goffman goes on to argue that a language of ‘relationships 
not attributes’ (pg. 4) is needed, meaning that stigma is caused by how society relates to a 
specific attribute rather than a core or fundamental problem inherent in the attribute. Building 
on Goffman’s original work, Link and Phelan (2001, pg. 363) argue that there are four core 
components that are required for stigmatisation to take place: Component 1: “The ability to 
distinguish and label differences”; Component 2: “Relating human differences with negative 
attributes” ; Component 3: “Separating “us” from “them””; Component 4: “status loss and 
discrimination”.  
Link and Phelan (2001) argue that the vast majority of human differences, whilst 
easily and readily observable, are ignored and therefore become socially unimportant. For 
example; differences between an individual’s fingerprints or size of their ears are not major 
sources of stigma in the United Kingdom. However, the colour of an individual’s skin or the 





negative outcomes for the individual (Fernando, 2006; Kibria, 2008; Takeda, Helms, & 
Romanova, 2006). Historically, people who have experienced seizure have been viewed 
negatively (Wolf, 2010). Seizures have been linked to witchcraft and possession (Jilek-Aall, 
Jilek, Kaaya, Mkombachepa, & Hillary, 1997), and there is evidence that similar views 
continue to be prevalent (Millogo et al., 2019). Therefore, Link and Phelan argue, there is a 
‘social selection’ (pg. 367) as to which human differences matter and therefore might be 
associated with stigmatisation and those that do not.  
This construction of social differences relies on the cognitive oversimplification, a 
process by which individuals categorise and sort information into small, manageable chunks 
(Gigerenzer, 2008). Link and Phelan give the example of society dividing race into ‘black’ 
and ‘white’, whilst ignoring the nuances of ethnicity, culture and the different shades of skin 
colour.  
Link and Phelan (2001) further note that labels which are deemed socially acceptable 
differ depending upon time and place. An example of this is given by Eknoyan (2006), who 
reports that being ‘fat‘ was socially regarded as a positive, being a sign of success and wealth. 
Eknoyan charts the change in perceptions of being overweight from the nineteenth century 
change to finding the aesthetic of being overweight as unattractive to more recent times 
where being overweight can be regarded as both unattractive and as a sign of moral 
weakness.  
As part of the second step of the process of stigmatisation, Link and Phelan argue that 
once an individual has been labelled, that person is then linked to a stereotype. In this 
context, a stereotype is a group of objectionable characteristics from which individuals want 
social distance. It has been further argued that stereotyping is a resource-preserving device 





This essentially means that stereotypes make it easier and quicker for human cognitive 
processes to compute and categorise large amounts of information, whilst maintaining other 
cognitive processes. Evidence for this comes from a study using a dual task paradigm, where 
participants had to form impressions of targets whilst monitoring prose. Participants showed 
improved prose-monitoring when stereotyped labels were used in the impression-forming 
task (Macrae, Milne, & Bodenhausen, 1994). Devine and Sharp (2009) further argue that 
stereotypes are not only resource-preserving, but also automatic and preconscious. Evidence 
for this has come from a number of studies.  For example, Spencer et al. (1998) found that 
stereotype activation occurred following negative feedback after having glimpsed a face for a 
fraction of a second.  
Link and Phelan discuss the third characteristic of stigmatisation as the use of social 
labels and stereotypes to split ‘us’ and ‘them’ (2001). The ‘us’ and ‘them’ dichotomy is a 
fundamental pillar of group psychology and whilst it has been argued that hostility towards 
outgroups is not always intentional (Brewer, 1999), it can often be the result (Weisel & 
Böhm, 2015). Whilst the make-up of the ‘us’ and the ‘them’ can change over time and in 
different circumstances (Hamilton, 2015), the core process of attributing negative and 
socially undesirable characteristics to ‘them’ remains (Hamilton, 2015).  This attributing of 
negative and socially undesirable characteristics to out-groups can result in the members 
becoming dehumanised, which can be catalyst for perpetration of horrific acts (Haslam, 
2006).  
The fourth and final stage of Link and Phelan’s (2001) model for stigmatisation is that 
the stigmatised person experiences loss of status and discrimination. Link and Phelan argue 
that this is a crucial, but also often neglected in the literature, stage of the stigmatisation 
process. When an individual is set-apart and associated with negative and unpleasant 





For example, a study looking at the social media portrayals of individuals who experience 
seizures found that 41% of “tweets” were derogatory in nature (McNeil, Brna, & Gordon, 
2012), essentially meaning that social media may be a difficult and threatening experience for 
NEAD. The consequences of social exclusion can be serious. Individuals who have been 
stigmatised and experienced status loss often perform poorly on matrices related to 
professional attainment, psychological functioning and life expectancy, amongst others 
(Livingston & Boyd, 2010; Mittal, Sullivan, Chekuri, Allee, & Corrigan, 2012).  
Hatzenbuehler and Link (2014) have further developed this model and argue that 
stigma can at occur at different levels.  For example; stigma can occur at intra-personal 
(stigma towards the self), the interpersonal (person-to-person stigma) and finally to the 
structural-level (also known as institutional stigma; organisational and governmental laws 
that result in stigmatisation). An example of structural stigma is the legal restricts on driving 
for people who experience seizures.  A recent study from United States had indicated that 
seizures accounted for fatal car crashes less often (0.2%) than drunk driving (31%). 
Nevertheless, driving restrictions are common and a recent review focusing on driving and 
epilepsy found that driving restrictions are often listed as a major and important factor in the 
loss of independence. 
Stigma can be further categorised into perceived and enacted stigma (also known as 
internal and external). Perceived stigma is when individuals attribute the negative action and 
behaviours of others to be related to a negative characteristic of their self. A powerful 
example of this is shown in the Kochman and Sikkema (2002) study that found HIV-positive 
sex-workers were reluctant to access appropriate medical interventions because of their 
feeling of being unworthy of such care. Additional, Research also suggests that stigma can 
negatively affect help-seeking behaviours. A systematic review by Clement et al. (2015) 





seeking behaviours. Concern surrounding making disclosures regarding the mental health 
problem were found to be the most frequently reported stigma barrier. They found that young 
men, individuals from ethnic minorities and professionals in the military and health-care 
settings were the most likely to be discouraged from seeking help because of the stigma.  A 
further systematic review and meta-analysis by Schnyder, Panczak, Groth, & Schultze-Lutter 
(2017) had similar findings, although they suggest that it is the individual’s personal attitudes 
rather than the broad public opinion, which should be targeted for intervention.  
Delayed help seeking can have serious consequences for individuals with mental 
health difficulties (Dell'Osso & Altamura, 2010).  For example, a study by Bukh, Bock, 
Vinberg, and Kessing, (2013) found that remission rates for individuals who had experienced 
a major depressive episode and had not received treatment for 6-months were significantly 
lower than for individuals who had been treated more quickly. A systematic review by 
Nordentoft et al. (2009) looking at the efficacy of early intervention for individuals with 
schizophrenia found that early intervention resulted in better treatment outcomes. Therefore, 
the result of delayed treatment because of stigma related to treatment seeking behaviour can 
have serious personal and social consequences.  
In the context of the Link and Phelan’s (2001) model, delayed treatment seeking 
demonstrate how they had internalised society’s stigmatisation of them to the extent that it 
has become a core aspect of their personal narrative, preventing them from accessing 
lifesaving care (Yanos, Roe, West, Smith, & Lysaker, 2012; Yanos, Lucksted, Drapalski, 
Roe, & Lysaker, 2015).  
External stigma is when individuals are directly discriminated against by others, be it 





Pachankis (2015) found that transgender people were less likely to be offered jobs and 
receive appropriate healthcare than non-transgender people.  
The consequences of stigmatisation, as well as association loss of social standing and 
sense of power, has been further developed into a model for the development of mental health 
difficulties. The power threat-meaning framework (Johnstone & Boyle, 2018) posits that 
mental health difficulties develop as a consequence of fundamental inequalities in society, 
perpetuated by stigma, prejudice and discrimination. They argue that mental health 
difficulties are a response to experiences of powerlessness and associated threat. Examples of 
evidence for this comes to the finding that countries that have greater levels of social 
inequality and income disparity have higher prevalence of mental health difficulties (Pickett, 
James, & Wilkinson, 2006 Pickett  Wilkinson, 2010). 
Given the impact that experiences of stigma can have on physical and psychological 
health, it is unsurprising that researchers have also looked at the role stigma can play in the 
health of individual suffering with functional neurological disorders (FND) or Dissociative 
Neurological Symptom Disorder (DNSD) (e.g. Rommelfanger et al., 2017; Psychiatric 
Association, 2013). FND are conditions characterised by an involuntary inability to access 
motor, sensory, and/or cognitive functions. These symptoms are not related to the effect of 
disease or damage to the nervous system or caused by substance use (American Psychiatric 
Association, 2013; World Health Organization, 2018). FND are often regarded as a 
physiological manifestation of psychological difficulties (Ludiwick et al., 2018). Non-
epileptic Attack Disorder (NEAD) is a specific type of FND in which the individual suffers 
from seizures, phenotypically similar to epileptic seizures, but without the neurological 
correlates of an epileptic seizure (Francis & Baker, 1999;Alsaadi & Marquez, 2005; Reuber, 
2008). The causes of NEAD are unclear, although it has often been linked to maladaptive 





highlighted that personality pathology is more frequent in individuals with NEAD (Reuber, 
Pukrop, Bauer, Derfuss, & Elger, 2004). In particular, they found that maladaptive 
personality traits similar to Borderline Personality Disorder were more common than in the 
general population or patients with epilepsy. Further research by Green, Norman and Reuber 
(2017) has indicated that individuals with NEAD have higher levels of anxiety and 
depression than individuals with epilepsy, as well as difficulties related to attachment styles. 
This, coupled with the lack of a known physical aetiology, results in individuals with NEAD 
meeting the classification for a disorder of mental health, with the exception being 
individuals who present with malingering seizures (American Psychiatric Association, 2013). 
Many individuals with NEAD described the confusion between their diagnosis and epilepsy, 
even from health care professionals (Auxemery, Hubsch, & Fidelle, 2011) which can result in 
the construction of social differences can also be related to NEAD.  
NEAD is often diagnosed following a misdiagnosis of epilepsy and a subsequent lack 
of response to epilepsy specific treatment. A diagnosis of NEAD requires specialist testing 
(which involved video-electrographic, VEEG, recording of typical seizures) because it can be 
difficult to outwardly differentiate between epileptic and non-epileptic seizures. It is possible 
that an individual may be misdiagnosed with NEAD and actually be suffering with epilepsy, 
but there is little evidence for this in the available literature.  
Most non-epileptic seizures are perceived by patients as outside of their own control 
and, similarly to epilepsy, impair the individual’s normal sensory and cognitive functioning. 
Given the outwardly similar appearance of NEAD and epileptic attacks, individuals with 
NEAD are often initially misdiagnosed with epilepsy, and only receive the accurate diagnosis 
of NEAD after a delay of several years. Furthermore, it is recognised that epilepsy is a risk 
factor for the development of NEAD and some individuals will receive a mixed diagnosis of 





either have epilepsy or NEAD (Wissel et al., 2016). Specialised testing, including video-
electroencephalographic recording of typical seizures and clinical assessment by an expert 
may be required to differentiate between non-epileptic and epileptic seizures.  
NEAD is three to four times more common in women than men, with the onset of 
symptom frequently occurring in the teens or early 20s, although seizures can start at any age 
(Mellers, 2005). There are an estimated 15,000 people with a diagnosis of NEAD in the UK, 
with an estimated prevalence rate of 50 per 100,000 (Kanemoto, et al. 2017). 
 
The relationship between stigma and mental health disorders is well established 
(Clement et al., 2015; Schulze, 2007; Sharac, Mccrone, Clement, & Thornicroft, 2010).  
Research suggests that individuals with a diagnosis of a mental health disorder report 
experiencing more stigma than those with a physical health conditions, for example Glozier, 
Hough, Henderson, and Holland-Elliott (2006) found that psychiatric nurses were less 
sympathetic to colleagues returning to work after sick-leave related to mental health than they 
were to colleagues returning to work after physical illness (diabetes). The impact of stigma 
for individuals with mental health difficulties can also have serious consequences.  A 
systematic review by Sharac, McCrone, Clement, and Thornicrof (2010) found that mental 
health related stigma results in fewer employment opportunities, lower income and less 
resource allocation to mental health related care. Interestingly, the authors propose that not 
only would reducing mental health stigma be beneficial for the individuals, but also that 
society, as a whole, would gain a positive economic benefit. Another example of the stigma 
that individual’s with mental health difficulties experience is ‘Diagnostic-overshadowing’. 





As with many mental health disorders, individuals with NEAD have reported 
experiencing stigma related to their disorder, at an even higher rate than individuals with 
epilepsy (Rawlings, G.  Brown, & Reuber, 2017). There have been a number of studies 
examining stigma in NEAD populations, but as of yet no comprehensive review of the 
available literature has been conducted. Given the detrimental impact of stigma on quality of 
life (MacLeod, & Austin, 2003) and increased psychological distress (Earnshaw, & Quinn, 
2012), the present review aims to provide a better understanding as to how individuals with 
NEAD experience stigma, especially at diagnosis.  Therefore, the present systemic narrative 
review aims to systematically identify studies that have investigated the role played by stigma 




Database search: Databases were searched by title, abstract and key term. Searches 
were completed in MEDLINE, CINAHL, PsycINFO, SCOPUS, Web of Science and Google 
Scholar. Reference sections of the final papers were examined, and a forward citation search 
was completed. The search was conducted in July, 2019. 
Inclusion criteria:  
If studies were in English and in a peer-reviewed journal, then their titles and 
abstracts were scanned and included if appropriate. Papers were included is they related to 
individuals with NEAD or healthcare professionals discussing stigma, were focusing on 
measuring stigma for individuals with NEAD or were regarding an intervention related to 





Exclusion criteria: Studies were excluded if they made no mention of stigma 
experienced by individuals with NEAD or the attitude of healthcare professionals towards 
NEAD in relation to stigma were not related to the measurement of stigma in individuals with 
NEAD or interventions related stigma in individuals with NEAD.    
Search terms: Search terms relating to stigma and NEAD were used including: 
stigma, stigmatisation, NEAD, PNES and functional seizure disorder (see appendix A for full 
list of search terms). 
Data coding and extraction.  A data extraction and coding scheme (see Appendix B) 
was developed to extract important information from the final sample of studies. These 
included the author, publication date, country of origin, sample demographics, methodology 
(qualitative, quantities, mixed), measures and outcomes (if appropriate), statistical procedures 
(if appropriate), findings and conclusions. The resulting information was extracted and 
entered into a database. The primary researcher then interpreted and synthesised the data to 
address the research questions.  
Quality appraisal. Quality appraisal checklists from the Joanna Briggs Institute (JBI, 
2019) were used. Different JBI tools were used depending upon the study type. For 
qualitative research, the “Checklist for Qualitative Research was used” (appendix C). For 
cross sectional studies, the “Checklist for Analytical Cross Sectional Studies” was used 
(appendix D).  For randomised controlled trial (RCT) the “Checklist for Randomized 
Controlled Trials” (See appendix E). The JBI checklists cover between 8-13 questions that 
help the reader to consider different aspects of the quality of the paper, including potential 
bias and appropriateness of research methodology. The overall quality of each study was 
calculated by combining the scores form each item on the checklist and converting them into 





quality of a study (see appendix F for full rating breakdown). A second rater (trainee clinical 
psychologist) was used to check the reliability of the ratings. Cohens Kappa was used to rate 
interrater reliability, which resulted in “moderate agreement” (k= .49 (p<.001), 95% CI = .41 
- .57). Any disagreements were discussed jointly and a final rating agreed upon. JBI does not 
indicate a minimum score by which papers should be excluded, therefore no papers were 
excluded based on their checklist sores. However, the checklist scores were combined to 
interpret the finding of the study.  
Results 
All of the databases were searched systematically using the identified search terms, 
resulting in the retrieval of 2310 papers. Any duplicates were excluded. The remaining papers 
were screened by title for relevance, applying the inclusion/exclusion criteria.  Forward and 
backwards citation search of the remaining articles were conducted. In total, 26 full-text 
articles were considered. Four were excluded for reasons provided in figure 2. This resulted 
in the inclusion of 22 for the final synthesis. All of the included were papers were screened 























Study Characteristics  
Detailed study characteristics can be found in table 1. Twenty-six full-text papers 
were considered for inclusion and four of these were excluded for reasons provided in figure 
1. This resulted in 22 papers being included in the review. Of the 22 articles 9 reported cross-
sectional studies, one reported a randomised controlled trial and 12 reported qualitative 
studies. One sample was analysed in two separate studies (Rawlings, Brown, Stone, & 
Reuber, 2018; Rawlings, Brown, & Reuber, 2019), however both were included because they 
looked at the participant data using different qualitative methodology and covering different 
topics.  
Quality appraisal 
All papers were checked for quality using the appropriate JBI quality checklists (see 
appendices C, D, E). All studies were included regardless of quality appraisal and the 
appraisal was used for informational purposes only and to facilitate commentary on the 
overall strengths and weaknesses of the research area. The mean quality percentage for all 
studies was 80%, with a range of 50-90%. For quantitative studies, the mean was 79%, with a 
range 50-87.5%. For qualitative studies, the mean was 81%, with a range of 70-90%.  
Stigma and NEAD 
All of the studies included discussed the role of stigma in individuals with NEAD. Upon 
examination, the articles can be divided into the following themes: 
Adjusting to diagnosis: Five studies examined how individuals adjusted to a 
diagnosis of NEAD. Being diagnosed with NEAD, especially for those who had previously 
been diagnosed with epilepsy, was a common source of stigma (Wyatt, Laraway & 
Weatherhead, 2014; Pretorius & Sparrow, 2015; Pretorius; Karterud, Knizek, & Nakken, 





using Thematic Analysis (TA) to highlighted concerns that many people felt that 
psychological treatment would not be any more effective than anti-epileptic drugs (AED), 
and was another hurdle before reaching a final diagnosis or help. Another theme found in 
several studies to be associated with the diagnosis process was the sudden change from a 
“physical” to a “psychological” disorder, and many studies indicate stigma was associated 
with the shift to use a “mental health” label (Wyatt, Laraway, & Weatherhead, 2014; 
Pretorius & Sparrow, 2015).  This is exemplified by “Lisa” in Wyatt, Laraway, and 
Weatherhead’s (2014) study, where one of the six interviewed  participants believed that a 
diagnosis of NEAD would result in her being detained in a “psychiatric hospital” (pg. 405). 
Pretorius and Sparrow (2015), who investigated adjustments to diagnosis’ of NEAD in a 
South African population, found that many participants found a psychological cause to be 
stigmatising and that there was also an underlying belief that psychological problems were 
less “real” (pg. 36) than physical problems. Similarly, questionnaire based studies by Tong, 
An, Reuber, Zhang, and Zhou (2018), found that many HCPs in China reported that many 
individuals diagnosed with NEAD declined the support of mental health services because of 
the stigma associated with having mental health difficulties. McMillian, et al. (2014) 
conducted a large qualitative study with 74 HCPs who worked with veterans in the United  
States and found that they too found that many individuals with NEAD declined mental 
health services because of the stigma of having a mental illness. Similarly, Du Toit and 
Pretorius (2018) found that many individuals in Namibia struggled with being diagnosed with 
NEAD, predominantly because of the cultural stigma attached to mental health difficulties. 
This cultural stigma often stopped or delayed, individuals seeking psychological treatment.  
Pretorius (2016), also studying the experience of South Africans who had been 
diagnosed with NEAD, found that the attitude of some healthcare professionals (HCP) at 





was ‘faking it for attention’ (pg.3) and that the many HCPs were less supportive and 
empathetic when the cause of the seizures was attributed to “mental health” rather than “a 
medical issue” (pg. 3).  
Attitudes of HCP:  Four papers looked at the attitudes of HCPs towards NEAD. 
Yogarajah, Child, Agrawal, Cope, Edwards, and Mula (2019) sent questionnaires to 974 
London GPs regarding NEAD, of which 120 replied. They found that almost 75% continued 
to use the term “pseudo-seizures”, despite the pejorative connotations this term may have and 
the possible stigma it may cause (Barron, & Rotge, 2019). Indeed, a small number (n=8) of 
GPs continued to use the term “hysterical seizures”, despite this being regarded as “highly 
offensive” by individuals with NEAD (Dunne, Carolan, Swords, & Fortune, 2019).  
Additionally, this study highlighted that over 50% believed that the seizures were voluntary, 
again reinforcing the stigma that because individuals with NEAD lack the physical correlates 
of epileptic seizures, they have more volition over their seizures. These stigmatising attitudes 
may be a product of inexperience of supporting individuals with NEAD, with 89% of the 
General Practitioner (GP) who replied saying that they have seen less than 10 individuals 
with NEAD and approximately 50% who felt uncomfortable managing individuals with 
NEAD being “younger” GPs, who may have less experience than the “older” GPs. A cross-
sectional survey by Carton, Thompson & Duncan (2003), found that some GPs did not 
believe the diagnosis, despite being diagnosed by a specialist centre. They contacted the GPs 
of 84 newly diagnosed NEAD patients and, at follow-up, found that 10 of the GPs did not 
agree with the diagnosis and continued to prescribe potent Anti Epileptic Medications. The 
reason for this disagreement is not clear, but may be linked to the stigmatising attitude toward 
NEAD not being a valid disorder. It should be noted, however, that this study had the lowest 






A qualitative study using Grounded Theory by McMillian et al. (2014) also found that 
the attitudes of clinicians could be stigmatising. This study, which took place in the United 
States in Veterans Associations clinics, interviewed 79 HCPs (such as neurologists and nurse 
practitioners). Many of the HCPs interviewed displayed stigmatising attitudes towards 
individuals with NEAD. A major theme was that individuals with NEAD were malingering 
or trying to maximise their opportunity for disability benefits. A high-quality qualitative 
study by Du Toit and Pretorius (2018), looked at the attitudes of HCPs in Namibia, found that 
many HCPs reported stigmatising attitude of their peers. They reported that many HCPs did 
not regard NEAD as a valid disorder, and one participant highlighted an example of a patient 
being refused hospitalisation by a medical aid because the individual did not regard NEAD as 
a disorder that would ever require hospitalisation. Stigmatising attitudes were also displayed 
by some respondents themselves. For example, they highlight that one participant stated that 
“I don’t think that they [the public] know that there can be a difference between real seizures 
and pseudo-seizures” (pg. 50). This comment again uses the stigmatising and invalidating 
terminology of ‘pseudo-seizures’ but also reinforces the unhelpful dichotomy of real seizures 
vs. not real seizures, as highlighted by David (2012.) 
Worsely, Whitehead, Kandler, and Reuber (2011) also investigated the attitudes of 
HCPs (although not including medical doctors) towards individuals with NEAD. This high-
quality  cross-sectional quantitative study used the adapted Illness Perception Questionnaire- 
Revised and the Symptom Attribution Questionnaire for epilepsy and PNES. They found that 
most HCPs believed that individuals with NEAD had control over their seizures and that 
NEAD was less chronic than epilepsy. Again, these views minimise the difficulties faced by 
individuals with NEAD and reinforces the stigma associated with this disorder. Tong, An, 
Reuber, Zhang, and Zhou (2018) also quantitatively reviewed the attitudes of HCPs, although 





address stigmatising attitudes of HCPs, it did find that neurologists would invite less than half 
(41%) of individuals with NEAD back for a follow-up appointment following diagnosis, and 
that many of those invited back may have co-morbid epilepsy. The reason for the lack of 
follow-ups is unclear, but may be linked to NEAD not being regarded as a “medical” 
condition in urban China and therefore not suitable for further medical treatment.  The lack of 
professional experience of managing NEAD by HCPs, and the resulting stigma, was 
highlighted by Higray et al. (2018). In this global quantitative study, they found that many 
HCPs believed that a lack of education related to NEAD resulted in stigmatising attitudes and 
interactions with patients.  
Experiences of Stigma. A high quality cross-sectional study by Robson, Myers, 
Pretorius, Lian, and Reuber (2018) found that many individuals with NEAD experienced 
stigma. They used the “Epilepsy Stigma Scale” to measure stigma and found that individuals 
with NEAD reported experiencing higher than average levels of stigma. They also found a 
negative correlation with health-related quality of life (as measured by the “Quality of Life in 
Epilepsy”), indicating a link between stigma and quality of life. A study by Rawlings, Brown, 
and Reuber (2017) also found that individuals with NEAD are 42% more likely to report 
stigma than those with epilepsy. They also found that whilst stigma was correlated with 
symptom severity for epilepsy, it was not with NEAD. This suggests that individuals’ 
perception of their disorder, influenced enacted and structural stigma, may be more important 
in the perpetuation of stigma than the disorder’s physical manifestation.  
This sense of stigma regarding their disorder is also highlighted by Vaidya-Mathur 
(2018), in a quantitative study based in the United States, looking at the socialisation 
characteristics of individuals with NEAD. This study found that 12% of respondents stated 
that social stigma related to their disorder stopped them from socialising. Unfortunately, this 





compared to other disorders. However, it may be telling that 41% of respondents reported 
being single compared to a national average of 26.9% and that 30.5% of individuals with 
NEAD reported that they were married compared to a national average of 56.4%. A narrative 
analysis by Rawlings, Brown, and Reuber (2018) also found that social stigma was a 
component in one of the important narratives that emerged from writing about living with 
NEAD. Social stigma was an important aspect of “tackling adversity” and participants 
discussed difficult social interactions, such as others saying that the individual with NEAD 
was faking a disability. Whilst the participant suggested that this specific interaction was said 
in jest, they also expressed hurt and disappointment at this attitude.  
The theme of social stigma also emerged from a qualitative study by McWilliams, 
Reilly, McFarlane, Booker, and Heyman (2017). This study reported on the stigmatisation 
faced by young people with NEAD and their families. Several young people and their 
families reported that they had faced stigma from schools, including the school asking for the 
young person to not attend because of NEAD. This resulted in some young people being 
home schooled and missing out on important social and educational opportunities. The 
impact of stigmatisation, social isolation and the subsequent negative impact on emotional 
development has been documented in young people with epilepsy (Hightower,  Carmon, & 
Minick, 2002) and this study by McWilliams, Reilly, McFarlane, Booker, and Heyman, 
suggests that the consequences for young people with NEAD may be the same. Karterud, 
Haavet, and Risø (2016) also highlight the role of social stigma in social isolation for young 
people. This qualitative study which took place in Norway, particularly emphasised that the 
belief that non-epileptic seizures were ‘fake’ as a significant source of stigma. They also 
discuss how NEAD could inhibit a young person’s ability to access employment, 





Experiences of stigma from HCPs. Robson and Lian (2017) conducted a large 
cross-sectional qualitative study looking at how individuals with NEAD in the UK, US, 
Ireland and Canada had experienced interactions with HCPs. Many respondents reported that 
HCPs often defined NEAD as not being epilepsy. This parallels with Link and Phelan’s 
(2001) first step of the stigmatisation process: “The ability to distinguish and label 
differences”. Individuals with NEAD felt that they had been clearly labelled as different and 
that the label had been defined in the context of a lack of epilepsy. Participants further felt 
that NEAD had been linked with negative connotations (such as malingering, lazy and faking 
for the purpose of disability fraud), which further parallels component 2 of Link and Phelan’s 
model (“Relating Human differences with negative attributes”). As highlighted by Robson & 
Lian, this can result in an “empathy gap” emerging for HCPs towards NEAD. This may result 
in the creation of a dichotomy between patients deserving and not deserving of empathy 
(Component 3 “Separating “us” from “them””). This can result in a myriad of difficulties 
(Component 4: “Status loss and discrimination”), ranging from an unwillingness to seek 
appropriate treatment (as highlighted by the papers mentioned above) to the high rates of 
unemployment as evidenced by 65% of respondents for this study being out of work.   
A qualitative study, by Rawlings, Brown, Stone, and Reuber (2018a) using written 
accounts of living with NEAD reports experiencing stigma from HCPs by individuals with 
NEAD. This study compared written accounts of individuals with Epilepsy and with NEAD. 
They found that almost all participants with epilepsy reported positive interactions with 
HCPs, but those with NEAD reported a significant number of negative interactions, including 
HCPs not believing their symptoms and/or believing that those with NEAD had control over 
their seizures. This is an example of Component 3 (“Separating “us” from “them””) of Link 
and Phelan’s (2001) model of the process of stigmatisation. It seems that many individuals 





patient who is less deserving of care. Some participants with NEAD reported that the stigma 
of their disorder and experience of negative interaction with HCPs had resulted in them 
avoiding health care services. Similarly, McWilliams, et al. (2017) found that many young 
people and their families had negative experiences from HCPs and schools. Similar themes 
emerged from a study by Fairclough, Fox, Mercer, Reuber, and Brown, (2013), looking at the 
perceived treatment needs of individuals with NEAD. They found that the stigmatising 
attitudes of some HCPs (such as accusations of faking etc.) resulted in confusion and 
ambivalence regarding treatment, particularly towards psychotherapeutic interventions.  
Public attitudes towards NEAD. Three studies highlight the poor public 
understanding and potentially stigmatising attitudes towards NEAD. Du Toit and Pretorius 
(2018) highlight that many HCPs regard the public understanding of NEAD in Namibia as 
being very poor. Some argue that the lack of public knowledge regarding NEAD can act as a 
barrier to treatment seeking and result in friends and family not being as supportive as they 
would be with other disorders. A large, high quality quantitative study by Carter et al. (2018) 
also found that many HCPs felt that a lack of public awareness of NEAD resulted in 
stigmatisation from both the general public and HCPs. In particular, many HCPs agreed that a 
lack of widespread understanding of the psychological mechanisms of NEAD delayed or 
stopped the use of psychotherapeutic treatment. Higray et al. (2018), in their large global 
study, found that many HCPs believed that a major barrier for diagnosis, treatment and 
causes of NEAD, was a lack of popular awareness of stigma.   
Treatments for stigma in the NEAD population. There is only one study looking at 
the role of stigma in possible treatment options. A RCT by Rawlings, Brown, Stone, and 
Reuber (18b), investigated the role of focused expressive writing (FEW), where the 
individual writes about distressing events for approximately 15-20 minutes. A study by 





individuals who experience shame and stigma. The study uses the Quality of Life in Newly 
Diagnosed Epilepsy (NEWQOL-6D), a measure of health-related quality of life, which 
includes questions related to stigma. The control group had to write about their actions and 
behaviours, whilst the treatment group had to focus on four ‘therapeutic’ topics. The results 
indicated that individuals in the treatment group showed a significant positive increase in 
their NEWQOL-6D scores than the control group. Whilst this treatment may not be specific 
to stigma, it may be a possible mechanism of change for potentially improving quality of life 
for individuals with NEAD. 
Discussion 
This review has aimed to investigate how people with NEAD experience stigma, if 
the attitudes of HCPs towards NEAD contributes to stigma, and if stigma has been targeted 
for treatment in this population.  Overall, a total of 22 studies were included for this review. 
JBI critical appraisal tools were used to check the quality of the papers. JBI scores ranged 
from 50% (which equates to acceptable quality) to 90% (very good quality). Ten of the 
studies used quantitative methodology and 12 qualitative methodology. Only two of the 
quantitative studies directly investigated stigma in NEAD, suggesting that this might be an 
under-researched area compared to epilepsy (Jacoby, 2008; MacLeod, & Austin, 2003). A 
wide range of different measures were also used to assess stigma in HCPs and those with 
NEAD, but none were specially validated in a NEAD population, with many using measures 
designed/validated in epilepsy as proxies.   
Evidence suggested that individuals with NEAD report more stigma than individuals 
with epilepsy (Rawlings, Brown, & Reuber, 2017). This support research by Looper and 
Kirmayer, (2004), which found that individuals with functional disorders reported higher 





evidence from this review that individuals with NEAD report high levels of stigma and that 
stigma is negatively correlated with quality of life. Research suggests that lower quality of 
life is correlated with developing mental health difficulties (Alonso, et al., 2004). This 
suggests that the high levels of stigma experienced by NEAD, negatively impacts on quality 
of life, which may result in the development of further mental health problems.  
This could be particularly concerning, given that 6 papers suggested that the attitudes 
of HCPs, particularly at diagnosis, resulted in individuals with NEAD reporting that they 
would be less likely to seek support from HCPs, or attend appointments, in the future. In 
particular, the papers highlighted that the change from a ‘physical’ to a ‘mental’ illness was 
particularly difficult for individuals with NEAD. This is supported by evidence that stigma 
towards mental health problems is a significant factor in delayed treatment seeking 
behaviours (Schomerus, & Angermeyer, 2008; Schnyder, Panczak, Groth, & Schultze-Lutter, 
2017). The consequences of delayed treatment seeking can be serious, including an increase 
in the severity and duration of experiencing distress, and lower responsiveness to treatment 
(Bukh, Bock, Vinberg, and Kessing, 2013; Clement et al., 2015). Given the treatment gaps 
highlighted by Kanemoto et al. (2017), this delay in NEAD treatment could be particularly 
serious.   
Only one study looked at the role of stigma in treatment options for NEAD. Although 
not specifically focused on stigma, the study did find an improvement on NEWQOL-6D 
(which contains items focused on stigma) following 15-20 minutes of directed focused 
expressive writing (FEW). Smyth and Helm (2003) found that FEW was an effective and 
inexpensive, self-help treatment for individuals who had experienced trauma. Given the 
possible aetiological links between NEAD and trauma (Reuber, 2008), FEW may prove to be 
an effective and inexpensive treatment options for individuals with NEAD to reduce stigma 





Six articles also suggest that individuals with NEAD experience stigma from 
professionals after diagnosis. One study compared written accounts of living with NEAD to 
epilepsy and found that individuals with NEAD reported more negative and stigmatising 
interactions with HCPs then those with epilepsy. Research by Hederson et al. (2014) that 
many health professionals display stigmatising attitudes towards individuals with mental 
health problems. This includes questioning the legitimacy of the lived experience of the 
individuals with mental health problems (Corrigan, & Wassel, 2008). The reviewed literature 
suggests that this is a similar experience of individuals with NEAD, with many HCPs 
questioning the legitimacy of the diagnosis or regarding the seizure as ‘fake’. 
The description of poor care reported by individuals with NEAD is supported by 
research. There is evidence that individuals with mental health difficulties often received 
poor health care compared to individuals with physical health problems (Jones, Howard, & 
Thornicroft, 2008). This has often been linked to ‘diagnostic overshadowing’; when HCPs 
attribute health related problems to a single diagnosis, such as mental health or learning 
disabilities. ‘Diagnostic overshadowing’ may be a particular problems in functional disorders, 
given the already unclear aetiology, and the associated stigma (Shefer et al., 2015). 
Four papers also looked at the attitudes of HCPs themselves and found that many 
HCPs expressed attitudes that could be regarded as of a stigmatising nature. This included the 
continued use of outdated terminology (such as “pseudo-seizures” or “hysterical seizures to 
describe NEAD). Another finding was that many HCPs regarded NEAD seizures as often 
being voluntary, and as a mental and not physical disorder.  It has been argued that the 
dichotomy between true illness and malingering is more relevant than the dichotomy of 
mental or physical illness. David (2012) argues that voluntary vs. involuntary is a more 
helpful way to regard NEAD seizures. An involuntary seizure is when the individual has no 





seizures would fall into this category. A voluntary seizure would be when an individual has 
control of when they present with seizure like symptoms and would often be in the context of 
medical malingering. David argues that the aetiology of the seizures (be it physical or 
psychological) is important in the context of treatment but otherwise is irrelevant if the 
seizures are involuntary. By also regarding, the seizures as involuntary and not simply the 
product of mental health difficulties may help to reduce the stigma some HCPs have towards 
mental health difficulties (Henderson, et al., 2014).  
Many individuals with NEAD, and HCP, highlighted the lack of knowledge in HCPs 
and also the general public. Work by Hederson et al. (2014) suggestions that improving 
educational resources for HCPs on mental health difficulties can help to reduce stigmatising 
attitudes. Three studies highlighted that public attitudes towards NEAD was also commonly 
regarded by HCPs as a source of stigma and a potential barrier to treatment. The link between 
negative public attitudes towards a disorder and delayed treatment seeking and poor 
outcomes is also supported by the research for mental health difficulties (Mojtabai, 2011).  
Limitations  
The outcomes of this review should be interpreted in the context of a number of 
limitations. Firstly, all of the papers included were published in English. They were also all 
drawn from peer-reviewed journals. Therefore, the included articles may not be a 
comprehensive reflection of the available literature of stigma and NEAD. It also opens the 
review to the possibility of publication bias, given that studies showing a positive link 
between NEAD and epilepsy were more likely to be published. It should be noted that the 
grey literature was searched, but no un-published work was found. It may, therefore, be that 





Secondly, many of the quantitative studies are of a correlational nature. Therefore, it 
is difficult to establish causality. No longitudinal studies looking at NEAD and stigma pre- 
and post-diagnosis of NEAD. Therefore, the high levels of stigma found in NEAD may have 
been present before the diagnosis and could have been linked to the aetiology of the disorder. 
Additionally, there was a lack of research exploring the link between stigma and other factors 
such as depression and anxiety. There is also little research on whether reducing stigma is a 
useful mechanism-of-changed for treatment Future longitudinal research focusing on stigma 
is warranted, particularly charting stigma pre-and post-diagnosis and pre- and post-treatment. 
Whilst many of the studies were of a high quality, the investigators positionality and 
reflexivity were rarely stated in the qualitative. It is therefore difficult to consider any 
potential influences the investigators may have had on the participants, data and 
interpretation. Additionally, how this bias was accounted for in the results in rarely discussed.    
Another limitation is that whilst many HCPs and individuals with NEAD stated that 
they perceived public attitudes towards NEAD to be a source of stigma, there was no direct 
evidence of this. A study investigating the awareness and attitudes towards NEAD in the 
context of stigma would be useful to establish public attitudes towards NEAD. This would 
help establish the level of stigma towards NEAD, direct and target any intervention to reduce 
negative public attitudes towards NEAD and allow a greater understanding of the 
mechanisms of stigma in NEAD.  
Finally, given the variation in methodology and measurement of stigma, a meta-
analysis was not completed. Therefore, researcher bias could influence the finding from this 
review. Although attempts to minimise bias through the use of objective coding and 





own positionality. A future review could include more researchers in the interpretation and 
synthesis, which may help to reduce this bias.  
Clinical implications 
Despite the limitations highlighted above, a number of clinical implications can be 
drawn from this review. Many individuals with NEAD reported experiencing stigmatising 
attitude and terminology from HCP. Therefore, it is important for HCPs to be aware of how 
they are being perceived by individuals with NEAD and to be aware of current literature 
related to non-stigmatising terminology. It may be helpful for HCPs to consider the voluntary 
vs. involuntary diagnosis, rather than regarding NEAD in the context of a physical/mental 
health dichotomy. It may also be beneficial for HCPs to improve their understanding of 
NEAD given its relatively high prevalence, (Reuber, 2008), and to promote education of 
NEAD among peers and the public. This may help to reduce stigma towards NEAD and 
reduce barriers to treatment seeking.  
In terms of direct treatment options, it may be beneficial for psychotherapeutic 
interventions to consider the role of stigma in NEAD, especially in the context of quality of 
life. Research stated in the qualitative studies suggests that psychotherapy can be effective in 
reducing self-stigma (Wykes, & Hayward, 2006; Macinnes, & Lewis, 2008). Therefore, 
psychotherapy may be effective in reducing self-stigma in NEAD and improving quality of 
life. The use of FEW for NEAD may also be effective and should be considered as a possible 
treatment option, especially given that it would be an inexpensive intervention.  
 Conclusion 
In conclusion, the current review suggests that individuals with NEAD experience 
stigma related to their disorder. They report that they experience stigma from both HCPs, 





intervention for reducing stigma in NEAD. These findings should be considered in the 
context of possible researcher and publication bias. Therefore, further investigation of this 
topic is warranted. In particular, longitude studies investigating NEAD pre-/post-diagnosis 
and pre-/post-treatment would help to better evaluate the relationship between stigma and 
NEAD and establish additional mechanisms of reducing stigma. 
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Appendix A – Full list of search terms 
Search terms related to NEAD and stigma (OR used within columns) 
 
NEAD 
Non-epileptic attack disorder 




psychogenic non epileptic 
seizure 
non-epileptic attack 
non epileptic attack 
non-epileptic seizure 
non epileptic seizure 
psychogenic seizures 




















































































Part II: Research report 
A cross-sectional study examine the relationship between Stigma and Self-Efficacy in 




















This study aimed to investigate the relationship between perceived stigma and self-
efficacy, depression, anxiety and symptom severity.  
Method 
120 individuals (NEAD = 68, Epilepsy = 52) were recruited from online support 
groups and in-person from a seizure clinic in the UK. Participants completed measures of 
perceived stigma, depression, anxiety and symptom severity.   
Results 
There were no differences in scores for participants recruited online or in-clinic. 
Participants with NEAD reported higher levels of perceived stigma (p=<0.05), depression 
(p=<0.01), anxiety (p=<0.05), and number of seizures experienced per year (p=<0.05), than 
those with epilepsy. Depression was above the clinical cut-off on the PHQ-9 for NEAD (M = 
14.10)  but not for Epilepsy (M = 9.32). Correlation analysis found that symptom severity 
was not correlated with perceived stigma for NEAD  (r = .17) but it was for epilepsy (r=.43, 
p=<0.01). Multiple regression for both NEAD (p=<0.01) and epilepsy (p=<0.05), found that 
depression significantly predicted perceived stigma.  
Conclusions 
Results indicated that individuals with NEAD reported more perceived stigma than 
those with epilepsy and higher, clinical levels of depression. The severity of symptoms was 
not associated with perceived stigma for NEAD but it was with epilepsy. Depression was 






• Individuals with NEAD report high levels of depression , above the clinical cut-off 
for the PHQ-9 
• Individuals with NEAD report higher levels of perceived stigma than those with 
epilepsy.  
• Depression was predictive of perceived stigma for both epilepsy and NEAD.  
Limitations 
• The cross-sectional nature of this study makes it hard to establish causality regarding 
stigma for NEAD and epilepsy.  
• Given the different aetiologies of NEAD and epilepsy, comparing the different 
disorders may be a limitation.  
• The depression measures (PHQ-9) may measure some aspects of the symptomology 
















Stigma can be defined as when a feature causes an individual and/or groups to be 
negatively differentiated from others based on a real or imagined characteristic (Goffman, 
1962, 2009). Goffman, in his seminal work, posited that stigma can stop an individual and/or 
group from gaining full ‘…social acceptance’(pg.4). Evidence suggests that when individuals 
perceive that they are feeling stigmatised, there can be significant and long-term negative 
impacts upon their mental and physical health, as well as their prospective attainment 
(DeWall et al., 2010; Arslan, 2018; Connolly, 1989). The concept of stigma has been well-
researched in the fields of physical and mental health, with evidence suggesting that 
individuals may experience stigma differently, by nature and degree, based on their specific 
disorder (Link & Phelan, 2001; Corrigan, Watson, & Barr, 2006; Taft et al., 2011).  
Since Goffman’s time the concept of stigmatisation has been elaborated and is not 
now considered to be a unitary concept. More recent work by  Hatzenbuehler and Link 
(2014) suggests that stigma can be regarded as occurring at multiple levels;  from the intra-
personal (stigma towards one’s self) to the interpersonal (stigmatization from a person 
towards a person) and finally to the structural-level (also known as institutional stigma; 
governmental policies and laws that are targeted at specific groups to cause social exclusion). 
The term ‘enacted’ stigma (also known as ‘external’ stigma) is used to describe stigma 
occurring at the interpersonal and/or structural level and is when and individual and/or group 
is treated pejoratively in a tangible way (Major & O'brien, 2005; Hatzenbuehler & Link, 
2014). For example, being refused care because of religious beliefs or denied a job because of 
race. An example of enacted stigma at the structural level can be found in a study by 
Pachankis et al. (2015), who looked at the consequence of country level laws and policies 
designed to impede or restrict homosexual men. The study found that the homosexual men in 





example in Russia and Ukraine) had fewer sexual partners and reduced access to HIV-
preventive services.  
‘Perceived’ stigma (also known as ‘internal’ stigma) is a concept used to denote when 
an individual characterises the negative behaviour and actions of others to a specific 
characteristic of their self (Pryor, Reeder,Yeadon,& Hesson-McInnis, 2004). This can be a 
result of the internalisation of negative stereotypes and prejudices linked to the perceived 
stigmatising characteristic (Miller & Kaiser, 2001). A European cross-sectional study by 
Alonso (2009) demonstrated that individuals are less likely to seek support and care for 
mental health difficulties if their reported degree of perceived-stigma is higher.  
Individuals feeling stigmatised can have serious consequences, such as reduced 
quality of life (Ross, 2017), lower rates of employment (Link, Castille, & Stuber, 2008) and 
less overall life satisfaction (Rosenfield, 1997). Given these consequences of perceived 
stigma, there has been much research looking at the links between perceived stigma and 
treatment outcomes in the fields of physical and mental health (Hatzenbuehler, Phelan, & 
Link, 2013). For example, several studies have found a relationship between seeking 
treatment and perceived stigmatisation in conditions ranging from substance use disorders to 
mental health For example; high levels of perceived stigma were associated with reduced 
reported quality of life in individuals with schizophrenia (Cooper, Campbell, Larance, 
Murnion, & Nielsen, 2018; Staring et al. 2009; Jacoby & Austin. 2002; Cataldo, Jahan, & 
Pongquan, 2012; Lillis, Levin, & Hayes, 2011) 
Epilepsy is a relatively common neurological disorder with over 500,000 individuals 
estimated to be affected in the UK (Epilepsy Society, 2018).  Epilepsy can be described as a 
disease of the brain, when an individual experiences at least two unprovoked or reflex1 
 





seizures that occur at least 24 hours apart or one unprovoked (or reflex) seizures. The 
likelihood of additional seizures increases to 60% after two unprovoked seizures (Fisher et 
al., 2014). A number of different factors (for example, brain lesions) can cause epilepsy but 
for up to two-thirds of individuals suffering with epilepsy, there may be no known cause 
(Cull & Goldstein, 2002). Individuals with epilepsy have no or very little control over when 
they experience seizures and the rate at which people can experience seizures can vary 
greatly. Epilepsy can be treated with both medication and life-style management, but about 
one third of individuals continue to experience seizures despite optimal management (Sirven, 
Pedley, & Wilterdink, 2018) 
There is a longstanding association of epilepsy with stigma (Holmes, Bourke, & 
Plumpton, 2019). Historically, epilepsy has been linked to spirit or demonic possession and 
as well as being thought to be contagious (Yildirim, Ertem, Dirican, & Baybas, 2019). 
Indeed, research suggests that, in some parts of the world, epilepsy continues to be 
mistakenly believed to be caused by witchcraft or possession rather than the result of a 
neurological disorder (Baskind & Birbeck, 2005). Whilst there is evidence that societal 
attitudes towards epilepsy are becoming more positive in UK, there is also evidence that 
prejudices towards individuals with epilepsy continue to exist in the UK (Holmes, Bourke, & 
Plumpton, 2019). Furthermore, there is also evidence that individuals with epilepsy continue 
to experience stigma related to their disorder, particularly in lower-socioeconomic status 
countries (Newton, & Garcia, 2012). 
Given the historical and widespread prejudices towards people with epilepsy, it is 
perhaps unsurprising that individuals with epilepsy perceive greater stigma than the general 
population (Jacoby, Snape, & Baker, 2005). These high levels of perceived stigma in 
individuals with epilepsy are associated with reduced quality of life. Indeed, in those with 





frequency (McLaughlin, Pachana, & Mcfarland, 2008). This may be because individuals who 
report high levels of stigma experience a high degree of shame and guilt related to their 
epilepsy (Van Brakel, 2006) meaning that they have lower-levels of self-worth (Claesson, 
Birgegard, & Sohlberg, 2007), self-efficacy (Baldwin, Baldwin,  & Ewald, 2006) and are less 
like to access social and/or medical support (de Souza & Salgado, 2006) 
Non-epileptic Attack Disorder (NEAD) is a condition whereby an individual 
experiences attacks that are outwardly similar to epileptic seizures, but that are not associated 
with the neurobiological correlates of epilepsy (Benbadis, 2005). NEAD is a relatively 
common with an estimated 15 000 people with a diagnosis in the UK (Kanemoto, et al., 
2017). Similar to epileptic seizures, most episodes of ‘seizure’ are not wilfully produced and 
typically result in a temporary disruption of normal functioning in visual, sensory, and 
cognitive domains. In the absence of specialist testing (involving video-electrographic, 
VEEG, recording of typical seizures) it can be difficult to differentiate between epileptic and 
non-epileptic seizures. As such, most individuals with NEAD initially receive an erroneous 
diagnosis of epilepsy, and experience invasive procedures and/or are prescribed potent 
antiepileptic medication before receiving an accurate diagnosis (Francis & Baker, 1999; 
LaFrance et al., 2013; Reuber et al., 2002).  
Current research indicates that, like those with epilepsy, individuals with NEAD often 
experience a significant amount of perceived stigma (Karterud, Knizek, & Nakken, 2010; 
Rawlings & Reuber, 2016; Rawlings, Brown, Stone, & Reuber, 2017). Given the lack of 
biological correlates for NEAD, it is often regarded as a medically unexplained symptom 
(MUS: Oto et al., 2005) or Somatic Symptom Disorder.  The current Diagnostic and 





“A) One or more somatic symptoms that are distressing or result in significant 
disruption of daily life.  
B) Excessive thoughts, feelings, or behaviours related to the somatic symptoms or 
associated health concerns as manifested by at least one of the following:  
1. Disproportionate and persistent thoughts about the seriousness of one’s symptoms. 
2. Persistently high level of anxiety about health or symptoms. 
3. Excessive time and energy devoted to these symptoms or health concerns. 
C) Although any one somatic symptom may not be continuously present, the state of 
being symptomatic is persistent (typically more than 6 months).” 
MUS terminology is, however, controversial. Bansal and Burton (2019) argue that the 
term can be a distancing factor in the clinician/patient relationship and that it can trivialise 
and be dismissive of patient’s individual experiences (see also; Greco, 2012). Marks and 
Hunter (2015) reported that only 15% of patients had positive attitudes towards the term 
MUS or Somatic Symptom Disorder.  Consequently, the term ‘persistent physical symptoms’ 
has been suggested as a more appropriate label. However, given that this term is not currently 
in common usage, MUS will continue to be used for the sake of clarity.   
Thus most patients with NEAD fulfil the diagnostic criteria of a mental health 
disorder (American Psychiatric Association, 2013; World Health Organisation, 2011). There 
has been a significant amount of research looking at perceived stigma in individuals with a 
metal health disorder, in particular as a barrier to accessing treatment/support (Sickel, Seacat, 
& Nabors, 2014). There is evidence that the degree of reported stigma differs between 





(Patten et al., 2016), meaning that most mental heath disorders report a similar degree of 
stigma.  
A number of different possible explanations for the underlying causes of NEAD have 
been suggested, but recently the Integrative Cognitive Model (ICM: Brown, & Reuber, 2016; 
Reuber & Brown, 2017) has offered the most comprehensive and integrated explanation. The 
ICM (Brown, 2004) combines previous theories of dissociation, conversion, and 
somatization. Dissociation is a detachment from one’s surroundings, often in reaction to 
intolerable emotional states, for example attempting to recall traumatic instances from one’s 
past. Indeed, frequency of disassociation has been linked to individuals experiencing 
significant past traumas (Kienle et al 2017). Conversion is when an individual experiences 
repressed emotional distress as physical illness. Research indicates that many individuals who 
experience medically unexplained symptoms, also have experienced significant trauma in 
their past (Brown, 2004). Both dissociation and conversion underpin the modern theory of 
somatization, the idea that psychological distress can be experienced as physiological 
symptoms. The ICM combines and expands all three theories into an integrative model. It 
proposes that information (such as traumatic memories) stored in an individual’s cognitive 
systems causes disruption to the interplay between conscious and preconscious information 
processing. This disruption is caused by an attempt to avoid and/or reduce the experience of 
emotions related to past trauma. The model then posits that symptom-focussed attention 
(hypervigilance for physical responses, catastrophization of identified symptoms, etc) results 
in the creation and maintenance of medically unexplained systems. Therefore the medically 
unexplained symptoms can be regarded as a form of maladaptive emotional regulation 
(Brown, 2004). The model further proposes that trauma is a significant factor in impeding 





The tenet of the ICM, as it relates to NEAD, is that the individuals develop internal, 
preconscious hypotheses about how best to respond to internal or external cues. Some of 
these hypotheses may be maladaptive (termed ‘rogue representations’ by Brown (2004)) but 
the individuals’ internal cognitive systems might regard them as the best and most adaptive 
response or explanation to the stimuli at the time. An example of this might be an individual 
experiencing high levels of anxiety and their internal, preconscious system might regard it to 
be better to experience a seizure than continue experiencing this emotion (see fig. 1). 
 
Fig. 1. The ICM of NEAD (Also known as Psychogenic non-epileptic seizures 
(PNES)). Important aspects are in the dashed area (from Reuber, Kanner, and Schachter, 
2008). 
There is a growing body of evidence for the ICM (Brown & Reuber, 2016). For 
example, a study by Garnefski, van Rood, De Roos, and Kraaij (2017), found that current 





history continue to cause strong and negative emotions in the present day. Furthermore, these 
somatic symptoms were significantly related to regular reported use of maladaptive cognitive 
coping strategies (e.g. self-blame, rumination, and catastrophisation) Additionally, a recent 
meta-analysis by Carlson and Perry (2017) found that 82% of individuals with NEAD who 
completed psychotherapy, reported a <50% reduction in seizures, supporting the cognitive-
affective underlying cause.  A study by Pick, Mellers, and Goldstein (2017) has indicated that 
individuals with NEAD report more past traumatic experiences than the general population 
Previous research has estimated the rates of a history of significant trauma in individuals with 
NEAD as being between 44-100% (Fiszman et al., 2004).  
It has been suggested that one possible method for reducing the impact of trauma on 
the individuals is to increase their perception of their self-efficacy (Benight & Bandura, 
2004). Self-efficacy is an individual’s perception of their ability or capacity to engage in 
behaviours that will contribute toward them attaining their goals (Bandura, 2010). A 
systematic review of 27 papers (N=8011) by Luszczynska, Benight and Cieslak (2009) 
examining the relationship between self-efficacy and trauma found that self-efficacy had a 
medium to large effect on levels of distress, as well as on the frequency and severity of PTSD 
symptoms. Additionally, they found that increasing an individual’s self-efficacy reduced 
misuse of substances and predicted fewer relapses. Samuelson, Bartel, Valadez and Jordan 
(2017), have also found that the self-efficacy moderates the relationship between traumatic 
events and the cognitive symptoms of PTSD.  A study by DeCou, et al. (2019), looking at the 
relationship between negative public attitudes towards sexual assault, and psychological 
distress, found that high self-efficacy levels was a significant factor in ameliorating 
psychological distress.  
An individual’s perception of their self-efficacy is not stable, and it can both increase 





efficacy can also be developed through direct training (Eden & Aviram, 1993). High rates of 
self-efficacy have been indicated as positive treatment predictors in a number of different 
clinical populations, including substance misuse (Burleson & Kaminer, 2005), heart disease 
(Clark & Dodge, 1999), and bulimia (Bardone-Cone, 2006). These treatment predictors 
include treatment compliance (Mici et al., 2019) and post-treatment adherence to lifestyle 
changes at follow-up (Müller, Znoi & Moggi, 2019). Therefore, increasing self-efficacy may 
help to reduce psychological distress associated with past traumatic events and improve 
treatment compliance in NEAD populations.  
Research has also established a link between perceived stigma and low self-efficacy. 
Kleim et al., (2008) found that higher perceived stigma scores in patients with schizophrenia 
were correlated with lower levels of self-efficacy regardless of symptom severity, insight, age 
and gender. Similar research by Landeen, Seeman, Goering, and Streiner, (2007), also found 
a correlation between perceived stigma and lower levels of self-efficacy in patients with 
schizophrenia. A study by Sung (2009), which took place in a Korean inpatient psychiatric 
hospital,  also found a link between higher degrees of stigma and lower self-efficacy, and 
hypothesise that this relationship may act as a mediator for the low levels of quality of life 
found in the study. A systematic review and meta-analysis by Livingston and Boyd, (2010), 
examining stigma in people living with mental health problems, found that there was a strong 
negative relationship between degree of stigma and self-efficacy (among other psychosocial 
variables), which in turn negatively impacted treatment compliance.  
As highlighted by Rawlings, Brown, and Reuber (2017) there is currently little 
available research examining the role of stigma in individuals with NEAD. The 
understanding of stigma in epilepsy is much further developed (De Boer, Mula, & Sander, 
2008). There is also little current available research comparing stigma in NEAD and epilepsy 





individuals with NEAD were four-times more likely to report perceived stigma than 
individuals with epilepsy.  
This study aims to investigate whether there are different reported levels of perceived 
stigma and self-efficacy in individuals with epilepsy and individuals with NEAD. There is 
little current literature looking at stigma in the NEAD population. Additionally, the study 
aims to understand how much of the variance within and between each population is 
accounted for by perceived self-efficacy. 
Primary Aim and hypothesis 
The primary aim of this study is to determine levels of perceived stigma and self-
efficacy in patients with epilepsy or NEAD and to investigate the relationship between these 
factors and anxiety, depression, and seizure severity.  The study specifically hypotheses that:  
1) Participants with NEAD will report higher levels of self-rated perceived stigma than 
participants with Epilepsy.  
2) Participants with NEAD will report lower levels of self-rated self-efficacy than 
participants with Epilepsy.  
3) Self-efficacy will account for a greater level of variance in perceived stigma scores 
across both groups than levels of anxiety, depressive symptoms, and seizure severity.   
4) Self-efficacy will account for a greater level of variance in perceived stigma scores 
than anxiety, depressive symptoms and seizure severity for participants with NEAD  
than participants with epilepsy 
Method 
Design 
The current study was a quantitative, cross-sectional questionnaire study determining 





that can be accounted for by perceptions of self-efficacy between two groups: Individuals 
with epilepsy and individuals with NEAD. 
Procedure 
Participants were recruited in two ways. Firstly, via the outpatient seizure clinic at a 
large teaching hospital. Secondly via online advocacy groups. All participants who were 
recruited via the outpatient clinics were initially sent a participant information sheet 
(appendix A) with their routine appointment letter, approximately one-month before their 
appointment. They were then approached in the clinic and asked if they wished to participate 
in the study. Individuals who stated that they wished to participate were given a pack with the 
participant information sheet (appendix A), the consent form (appendix B) and study 
questionnaires (below). Participant’s diagnoses were gleaned from their medical records 
following their signing of the consent form or from discussion with their neurologist if the 
diagnosis was unclear.  
The second group were recruited via online advocacy groups (Epilepsy Action and 
FND action). The study was advertised between July-August 2019 on their main page and 
advertised via their Facebook and Twitter platforms. Participants were asked to complete an 
online consent (appendix B) form and then asked to complete the questionnaires (below). The 
online questionnaire was hosted on Qualtrics. Online participants gave self-reported 
diagnosis to either NEAD or Epilepsy.  They were asked: “Please provide you diagnosis (e.g. 
epilepsy, NEAD, Mixed epilepsy and NEAD etc):”Demographic data regarding age and 
gender was also collected for both groups (appendix J) 
Ethics 







In order to be eligible to participate potential participants needed to be aged 16 or 
over and self-identify as having received a diagnosis of either epilepsy or NEAD. Individuals 
who reported they had a diagnosis of both were not eligible to be included. 
Information about the study aims, procedure, right to withdraw, how the data would 
be stored, potential risks and options for further support were sent via letter to the participants 
recruited in the outpatient clinic or were present on the within the survey for the group 
recruited online (appendix A). Informed consent was gained by completion of the Informed 
consent sheet (appendix B). All personal and identifiable information were kept on an 
encrypted password protected database accessible by the primary investigator. 
Questionnaires 
The survey included the following questionnaires: 
Stigma Scale for Chronic Illness (SSCI-8: Molina, Choi, Cella & Rao, 2013) (appendix 
D). The SSCI-8 is an eight-item questionnaire that measures internal stigma in individuals 
with neurological conditions (e.g. epilepsy, multiple sclerosis etc.). The reliability of the 
eight-item version of the SSCI has been demonstrated by Cronbach’s alpha exceeding 0.7 
(Cronbach’s alpha = 0.89) and the validity by exceeding Cohen’s Kappa of 0.40 with self-
reported psychological distress (Cohen’s Kappa = 0.42.7, SD = 19.7) (Rao et al., 2009).  
The General Self-Efficacy Scale (GSE: Schwarzer & Jerusalem, 1995) (Appendix 
E). The GSE is a 10-item scale designed to assess an individual’s perception of their ability to 
demonstrate personal mastery. The reliability of the GSE has been established by various 
studies with Cronbach’s alpha ranging from .76 - .90 (Scholz, Gutiérrez-Doña, Sud, & 





Generalised Anxiety Disorder-7 (GAD-7:Lowe et al., 2008) (Appendix F). The 
GAD-7 is a 7-item measure of anxiety that is used in various clinical settings. Scores of 5, 10, 
and 15 are considered cut-offs for mild, moderate and severe anxiety with a score of 10 often 
regarded as the individual requiring further evaluation when used as a screening tool 
(Plummer, Manea, Trepel, & McMillan, 2016). Reliability of the GAD-7 has been 
demonstrated by the Cronbach’s alpha exceeding 0.7 (Cronbach’s alpha= 0.89).  
Patient Health-Questionairre-9 (PHQ-9: Kroenke, Spitzer, & Williams, 2002) (Appendix 
G). The PHQ-9 is a widely used 9-item measure of depression. A cut-off score of 10 or 
greater (indicating symptoms of depression) produced a sensitivity of 89% (95% CI 0.83–
0.92) and specificity of 0.85 (95% CI 0.75–0.91) (Manea, Gilbody, & McMillan, 2012) for 
depressive Symptoms. Estimates of internal reliability range from 0.86 to 0.89 using 
Cronbach’s alpha (Kroenke, Spitzer & Williams, 2002). Test-retest reliability is estimated to 
be 0.84 with almost identical mean total scores.  
Liverpool Seizure Severity Scale – Revised (LSSS-3: Scott-Lennox, Bryant-
Comstock, Lennox, & Baker, 2001) (appendix H).The LSSS-3 is a 12-item scale that aims 
to assess the severity of an individual’s seizure symptoms. The LSSS has been widely used in 
the epilepsy population. There is currently no current scale available for individuals with 
NEAD but the LSSS-3 has been used in NEAD populations previously (Green, Norman, & 
Reuber, 2017). Therefore, the LSSS-3 was used to assess seizure severity in the NEAD 
group. The LSSS-3 has demonstrated good reliability with a Cronbach’s alpha of between 
0.78-0.87, depending upon the participant group. The validity of the LSSS-3 was 
demonstrated by showing a correlation between change scores on the LSSS-3 and clinician 






G*Power3 was used to determine the sample size required to prevent type II errors. 
An a priori power analysis for linear regression fixed model was used with an effect size of 
F2= 0.15 (Faul, Erdfelder, Buchner, & Lang, 2009), an alpha of 0.05 and power of 0.80 
(Bosco et al. 2015). This provides an overall sample size of 85. This has also been checked 
using Cohen’s (1992) table and resulted in a similar sample size (84). A comparable study 
(Green, Norman, & Reuber, 2017) has  been published and they were able to recruit 95 
participants. 
Analysis Plan 
All the data was analysed using SPSS IBM Corp version 26 (2017). To investigate if 
there were different degrees of reported stigma between the two groups, independent sample 
t-tests were used to compare participants with epilepsy and participants with NEAD reports 
of perceived stigma. Participant groups were the independent variables and the score on the 
SSCI-8 was the dependent variable.  
To understand if there were differences in reporting of self-efficacy between the two 
groups, independent sample t-test was used to compare participants with epilepsy and 
participants with NEAD for reported levels of self-efficacy. Participant groups were the 
independent variables and the score on the GSE were the dependent variable. 
Multiple regression analysis was used to investigate if self-efficacy (dependent 
variable) accounts for variance on the perceived stigma scores (independent variable) across 
both groups once the other dependent variables (levels of anxiety, depressive symptoms and 







Figure 1 shows the recruitment for online participants and figure 2 show the 





















A breakdown of the means and standard deviations for the different participant groups 
can be found in table 1 and 2. No significant differences were found on any of the self-report 
measures between online and clinic recruits in the epilepsy or NEAD groups. Participant data 
in the two clinical categories were combined for further analyses regardless of the source of 
recruitment (see tables 1 and table 2).  









Table 1: Participant means and standard deviations for NEAD 
participants in the online and clinic groups. 
Table 2: Participant means and standard deviations for Epilepsy 






Independent samples t-test 
To investigate if participants with NEAD will report higher levels of self-rated 
perceived stigma than participants with Epilepsy., independent sample t-tests were calculated. 
There was a significant difference (t(116)= 3.78,p=<0.01) between the scores for participants 
with epilepsy (n=55, M= 18.26 , SD= 8.46) and NEAD (n=44, M=24.15, SD= 7.94) . The 
effect size for this analysis (d= .66) exceeded Cohen’s (1988) convention for a medium effect 
size. These results indicate that participants with NEAD experience greater levels of 
perceived stigma than participants with epilepsy. There was no difference between 
participants with NEAD who were recruited online (n=55, M= 24.64, SD=7.50) and in clinic 
(n=13, M=21.31, SD=9.42) (t(66)=1.37 ,p=.18). Similarly, there no difference between 
participants with epilepsy who were recruited online (n=32, M=19.72, SD=9.50) and in clinic 
(n=18, M=15.67, SD=5.51) (t(48)=1.66, p=.104). 
To investigate if participants with NEAD will report lower levels of self-rated self-
efficacy than participants with epilepsy, independent sample t-tests were calculated. There 
was no significant difference in scores for participants with epilepsy (M= 25.49, SD=6.7) and 
NEAD (M = 26.71, 8.55 SD=6.69). This indicates that participants with both NEAD and 
epilepsy both report roughly comparable levels of self-efficacy.  
The mean score for the PHQ-9 and GAD-7 scales was above the clinical cut-off point 
for NEAD but not epilepsy. 41 participants with NEAD scored above the clinical cut-off on 
the PHQ-9 compared to 23 with epilepsy. 38 participants with NEAD scored above the 


















Multiple Linear Regression 
Correlation for participants with NEAD found that depression scores were correlated 
with anxiety, and perceived stigma and negatively correlated with self-efficacy. The analysis 
also found that self-efficacy was negatively correlated with anxiety and perceived stigma. 
Perceived stigma was correlated with anxiety (see table 4). For participants with Epilepsy, 
depression was found to be correlated with anxiety, and stigma and negatively correlated with 
self-efficacy. Self-efficacy was also negatively correlated with anxiety. Perceived stigma was 
correlated with depression, anxiety and symptom severity.  
 
 
























To investigate if self-efficacy explains variance in perceived stigma scores above any 
variance explained by levels of anxiety, depressive symptoms, and seizure severity, two 
Table 4: Correlation analysis for participants with NEAD 





multiple linear regression analysis was calculated for participant’s with NEAD and epilepsy. 
The data met the assumptions necessary for the use of regression analysis (appendix K).  
NEAD 
A multiple regression was carried out to investigate whether the independent variables 
could significantly predict participants’ with NEAD stigma scores. The results of the 
regression indicated that the model explained 36% of the variance and that the model was a 
significant predictor of stigma scores, (F (5,50) = 7.78, p< .000, R2 adjusted = .36). While 
depression scores contributed significantly to the model (β = .423, t(55) = 2.179,p= .<03), 
anxiety scores (β = .136,  t(55) = .72 ,p= .47 ), self-efficacy scores (β = -.14,  t(55) = -1.09 
,p= .28), seizure severity scores (β = .04,  t(55) = .37, p= .71) and number of reported seizures 
per year (β = .05, t(55) = .37, p=  .65) did not significantly contribute towards the model.  
Epilepsy  
A multiple regression was carried out to investigate whether the independent variables 
could significantly predict participants’ with NEAD stigma scores. The results of the 
regression indicated that the model explained 42% of the variance and that the model was a 
significant predictor of stigma scores (F (5,34)= 7.19, p<.000), R2 adjusted = .443). Again, 
depression scores contributed significantly to the model (β = .57, t(34) = 3.56, p= .001)  
scores on anxiety (β = -.09,  t(34) = -.6 ,p= .55), general self-efficacy (β = -.17,  t(34) = -.599, 
p= .26), seizure severity scores (β = .26,  t(34) = 1.87, p= .08) and number of reported 
seizures per year (β = -.05, t(34) = -.43, p= .67 ) did not significantly contribute towards the 
model.  
Discussion 
The results from this study suggest that depression may be predictive of perceived 





linking depression and perceived stigma (Manos, Rusch, Kanter, & Clifford, 2009) and 
similar findings have been found for participants with epilepsy by Rawlings, Brown, and 
Reuber (2017). Manos, Rusch, Kanter, and Clifford (2009) suggest a model that may help 
explain the link between depression and perceived stigma. Although their focus is on 
individuals whose primary diagnosis is major depressive disorder, they argue that the 
symptoms of depression lead to an increase in the salience of stigmatising attitudes. For 
example, an attempt to hide seizures may lead to the avoidance of social situations, which in 
turn may increase the depressive feelings and perceived stigma (Ottenbreit & Dobson, 2004). 
Research has also indicated that the feeling of stigma can be predictive of depressive 
symptoms (Griffiths, Christensen, & Jorm, 2008; Livingston, & Boyd, 2010). 
This is further supported by the finding that NEAD was associated with clinical levels 
of anxiety and depression, whereas epilepsy was associated with sub-clinical depression and 
anxiety. Evidence suggests that individuals who are depressed are more likely to appraise 
situations and social interactions negatively and show an impaired ability to recognise 
happiness in others (Joormann, & Gotlib, 2006; Leppänen, 2006; Surguladze, et al., 2004). 
This links to research which suggests the individuals with NEAD often report negative 
experiences of care from health professionals (Rawlings & Reuber, 2016; Rawlings, & 
Reuber, 2018) and that evidence suggests that there may be differences in interactions 
between individuals with NEAD and healthcare professionals compared with similar 
interactions between those with epilepsy and healthcare professionals (Monzoni, Duncan, 
Grünewald, & Reuber. (2011). Therefore, individuals with NEAD may be experiencing 
depression, which may make them more acutely aware of perceived stigma from others and 
more likely to regard interactions with others in a negative light. This may then be 





 The link between depression and perceived stigma in individuals with epilepsy is 
supported by existing research (Rawlings, Brown, and Reuber, 2017). It is interesting that 
individuals with NEAD reported higher levels of depression than individuals with epilepsy 
and that the NEAD populations mean scores were above the clinical cut-off whilst the 
epilepsy participants were not. Nevertheless, much of the proposed model by Manos, Rusch, 
Kanter, and Clifford (2009) may also apply to participants with epilepsy; depression 
increases the salience of stigmatising experiences.  
The higher depression and anxiety scores in NEAD also fits with the ICM (Brown, & 
Reuber, 2016; Reuber, & Brown, 2017). One possible explanation for NEAD suggested by 
the ICM is that the preconscious develops maladaptive responses (such as seizures) in 
response to internal or external stimuli. Seizures in NEAD might be regarded as a 
maladaptive form of emotional regulation. Therefore, higher levels of negatively experienced 
emotions would be expected in NEAD. It may also explain why symptom severity is not 
correlated with stigma in NEAD. The symptoms of NEAD may be easier to experience than 
intolerable emotional states that the seizures have been developed to avoid.  
The finding from this study differ slightly from previous research in that depression 
and anxiety were correlated with perceived stigma for NEAD and epilepsy. In the study by 
Rawlings, Brown, and Reuber (2017), they found that depression and anxiety were correlated 
with perceived stigma for participants with epilepsy but not NEAD. It should be noted that 
whilst this study used the same measure for anxiety (GAD-7) as the current study, a different 
measure of depression was used. Rawlings, Brown and Reuber used the Neurological 
Disorders Depression Inventory for Epilepsy (NDDI-E; Oliveira, et al., 2011), as this study 
used the PHQ-7. The regression analysis indicated that depression scores were predictive of 
perceived stigma scores. Difficulties with depression have been found to be a significant 





Szaflarski & Szaflarski, 2004; LaFrance & Syc, 2009) in the current research literature. There 
is also a well-established link between depression and perceived stigma (Pyne etal., 2004; 
Kanter, Rusch & Brondino, 2008; Manos, Rusch,  Kanter,  & Clifford, 2009).  
Whilst there was no significant difference in symptom severity scores, NEAD was 
associated with higher reported seizures than participants with epilepsy. However, for 
epilepsy, symptom severity was correlated with perceived stigma, indicating that the 
symptom severity was related to perceived stigma in epilepsy. This is despite there not being 
a meaningful difference in symptom severity between the two groups.  There was a 
significant difference in number of seizures experienced per year, with NEAD experiencing, 
on average, almost twice as many seizures as epilepsy. Therefore, despite experiencing more 
seizures and similar levels of symptom severity to epilepsy, the symptoms of NEAD were not 
linked to perceived stigma.  This suggests that there might be different mechanisms for the 
development and perpetuation of perceived stigma in NEAD and epilepsy.  
As expected, NEAD was associated with higher levels of perceived stigma than 
epilepsy. It is possible that the diagnosis of NEAD being regarded as a mental health disorder 
may be contributing to the high levels of reported perceived stigma, independent of symptom 
severity. There is a significant literature reporting on the stigma faced by those with mental 
health difficulties, at the intrapersonal (Corrigan, Watson, & Barr, 2006), interpersonal 
Couture, & Penn, 2003) and structural level (Corrigan, Markowitz, & Watson, 2004). As 
highlighted by Corrigan (2007), the diagnosis and label of mental illness may result in the 
person experiencing enacted stigma from professionals and the public, particularly in the 
form of stereotypes that perpetuate myths such as the homogeneity of mental illness and the 
lack of possible recovery. These arguments have been exemplified in research by Teachman, 
Wilson, and Komarovskaya, (2006) who found negative implicit attitudes (using the Implicit 





health difficulties and explicit negative attitudes regarding helplessness. Therefore, those who 
have been diagnosed with NEAD may have had implicit and explicit negative attitudes 
towards mental illnesses before their diagnosis, which may have contributed to the 
development of perceived stigma. It might also explain why symptom severity was not 
correlated with perceived stigma in NEAD, but it was in epilepsy; the stigma might be more 
related to the diagnosis rather than the symptoms. Teachman, Wilson, and Komarovskaya 
also found that these negative attitudes towards mental illness was not reduced in individuals 
with mental health problems, which may perpetuate the experiences of perceived stigma by 
NEAD.  
The fact that participants with NEAD reported greater degrees of perceived stigma 
than participants with epilepsy, is similar to previous research in this area (Rawlings, Brown, 
& Reuber, 2017). The research on stigma in MUS is more mixed. Research by Taft et al. 
(2011) indicated that participants with irritable bowel syndrome (IBS; MUS) showed greater 
levels of perceived stigma than participants with Inflammatory Bowel Disorder (IBD: non-
MUS). In contrast, research by Looper and Kirmayer (2004) indicated that whilst chronic 
fatigue syndrome (CFS) participants showed a greater degree of stigma compared to a 
matched medical condition with a clearer aetiology, participants with fibromyalgia (FM), or 
irritable bowel syndrome (IBS) showed no significant difference in perceived stigma scores 
to a matched medical condition. They argue that CFS has a greater medical ambiguity than 
FM or IBS. This may be similar for NEAD, which may, alongside the link to mental illness, 
explain the greater degree of perceived stigma.  
Some existing research suggests that for some physical disorders, symptom severity 
has been linked to perceived stigma. For example, Taft et al. (2009) found that participants 
with IBD who reported a higher degree of symptom severity, also reported greater perceived 





and psoriasis (Böhm et al., 2014). Whilst this was not the case for participants with NEAD, it 
was for participants with epilepsy in the current study, where there was a correlation between 
perceived stigma and symptom severity. This contrasts with the work of Rawlings, Brown, 
and Reuber (2017) who found that symptom severity was not correlated with perceived 
stigma in epilepsy. However they did find that seizure frequency was correlated with the 
sequelae of epilepsy, such as memory and concentration difficulties. It is possible that the 
highly visible nature of epileptic seizures may result in similar emotional responses to those 
who experience IBD and psoriasis. Symptom related shame is a well-researched concept in 
all three disorders and may be a common factor in symptom related stigma (Trindade,  
Ferreira, & Pinto‐Gouveia, 2017; Sampogna, Tabolli, & Abeni, 2012; Jacoby, & Austin, 
2007). 
Both NEAD and epilepsy were associated with similar levels of self-efficacy. This 
indicates that both groups felt themselves to be equally self-efficacious. There is little 
existing research looking at self-efficacy and perceived stigma in NEAD populations. 
However, there is existing research establishing a link between perceived stigma and self-
efficacy in participants with schizophrenia (Kleim,et al.2008), bipolar and depression  
(Brohan et al., 2011), alcohol abuse (Schomerus, et al. 2011), and gambling addiction (Hing, 
Nuske, Gainsbury, & Russell, 2016). Research by DiIorio et al. (2003) also found an 
association between perceived stigma and self-efficacy for participants with epilepsy. The 
correlation analysis suggests that there was not a link between self-efficacy and perceived 
stigma for participants with epilepsy, but there was for participants with NEAD. However, 
the regression analysis indicated that self-efficacy did not account for a significant degree of 
the variance in perceived stigma for either group. One possible explanation for this is the high 
degree to which depression and self-efficacy were negatively correlated in NEAD, but less so 





opposite) processes as the self-efficacy measure (GSE) in NEAD. The high correlation 
between depression and perceived stigma in NEAD may have also been capturing lower self-
efficacy; explaining the high correlation between self-efficacy and perceived stigma, but the 
low explained variance of self-efficacy in perceived stigma.  
There was no difference for participants recruited in clinic or online for either NEAD 
or epilepsy groups. This is perhaps surprising given that symptom severity might be expected 
to be higher in individuals who regularly attend clinics, but it cannot be ruled out that online 
participants were also regularly attending clinics. 
Strengths, Limitations, and future directions  
A major strength of this study is that it is, to our knowledge, the first study 
investigating the role of self-efficacy in perceived stigma in a NEAD and epilepsy 
population. As such, it contributes to the current literature on stigma and self-efficacy in 
NEAD. This study builds on the work of Rawlings, Brown, and Reuber (2017) in developing 
our understanding of the difference in stigma between NEAD and epilepsy.  
The finding from this study should be considered in light of a number of limitations. 
Firstly, the cross-sectional nature of the study makes it difficult to establish causality. A 
longitudinal study, specifically examining pre/post diagnosis may allow a better untangling of 
the nature of perceived stigma in NEAD. Additionally, all the data was self-reported, which 
could be regarded as a weakness of the study. It was not possible to confirm the diagnosis of 
the online participants, meaning that they may not have had a formal diagnosis or may have a 
mixed diagnosis of epilepsy and NEAD. Additionally, the participants were all drawn from 
the UK, meaning that it may be problematic to generalise these findings to NEAD and 





Furthermore, comparing epilepsy and NEAD populations might be a limitation of this 
study. The aetiology of epilepsy and NEAD is very different, despite the outwardly similar 
appearance of the seizures. A comparison with other functional or psychological disorders 
might be a more appropriate comparison, especially to establish the level of perceived stigma 
experienced in NEAD in comparison to similar disorders. The different aetiologies may also 
have meant that some questions used were not the most appropriate. For example; it is 
possible that that the SSCI taps into different processes for epileptic and NEAD participants. 
The link between diagnosis of mental illness and stigma is well established and therefore the 
SSCI may be measuring the stigma associated with mental illness rather than specifically 
stigma related to non-epileptic attacks (Rüsch, Angermeyer, & Corrigan, 2005). This may 
also explain why there was not a link between symptom severity and perceived stigma in the 
NEAD group but there was for the epilepsy group. The SSCI focuses on the perception of the 
relationship with others. As highlighted by Rawlings, Brown, and Reuber (2017), it may be 
that when measuring perceived stigma in participants with NEAD, some of the results may 
also be measuring difficulties with interpersonal relationships. Green, Norman, and Reuber 
(2017), report high levels of attachment difficulties in individuals with NEAD, therefore the 
SSCI may also be reporting interpersonal difficulties for participants with NEAD, rather than 
just perceived stigma.  
One possible explanation for the relatively high PHQ-9 scores in participants with 
epilepsy and the link between PHQ-9 scores and perceived stigma, is that some items of the 
PHQ-9 may be measuring symptoms of epilepsy, rather than symptoms of depression. 
Although the PHQ-9 has been validated for individuals with epilepsy (Rathore, 2014; Fiest, et 
al. 2014) Somboon et al., (2019) highlight how common insomnia is for individuals with 
epilepsy. Therefore item 3 on the PHQ (see appendix B) “Trouble falling asleep, or sleeping 





(“Feeling tired or having little energy”) and item 7 (“Trouble concentrating on things, such as 
reading a newspaper or watching television”) are similar to items on the LSSS (see appendix 
F; Item 4 “After my most severe seizures: I feel very confused” to “I do not feel confused at 
all”; Item 8, “After my most severe seizures: I always feel sleepy” to “I never feel sleepy”). If 
the high number of average yearly seizures (m= 120.62 per year) reported by patients with 
epilepsy is considered, it may be that elements of the PHQ-9 are also measuring symptom 
severity. It would also help to explain why there was a high degree of correlation between 
symptom severity, PHQ-9 and perceived stigma in the epilepsy group, but not in the NEAD 
group. A recent systemic review of depression screening tools for individuals with epilepsy 
by Gill et al. (2017) suggests that the Neurological Disorders Depression Inventory for 
Epilepsy (NDDI‐E: Gilliam et al., 2006) may be a better tool for measuring depression in 
individuals with epilepsy than the PHQ-9. It should be noted, however, that the study by 
Rawlings, Brown, and Reuber (2017) used the NDDI-E and found a positive correlation 
between depression scores and perceived-stigma.  
For future research, a longitudinal study, looking at stigma pre/post diagnosis might 
be helpful in understanding in causality in perceived stigma for NEAD, might help to address 
some of these limitations. A different comparison group for NEAD might also help to 
deconstruct perceived stigma in NEAD. It might also be beneficial for a different scale of 
stigma and depression to be used. The Stigma Scale (King et al., 2007), is a measure of 
stigma developed for use with people suffering from psychiatric and psychological 
difficulties. Therefore, it may be more suitable for NEAD and may be less influenced by the 
symptomatology of NEAD than the SSCI. The use of a different depression tool is more 
problematic, however, the use of  NDDI-E may be indicated for the NEAD population, 
especially given the very high correlation of the PHQ-9 and the SSCI found in this study.  





This study was a cross-sectional study, which investigated the relationship between 
self-efficacy, depression, anxiety, symptom severity, and perceived stigma in NEAD and 
epilepsy. The findings suggest that people with NEAD experience higher perceived stigma 
and depression than those with epilepsy, and that depression predicted stigma in both 
populations. Additional analysis found that symptom severity was not linked to stigma in 
NEAD but it was in epilepsy. Furthermore, that self-efficacy had a negative relationship with 
stigma in NEAD but not in epilepsy. This is an important finding for clinicians who work 
with NEAD, which suggests that depression might be a significant factor to target when 
planning therapeutic interventions. It would be beneficial for future research to consider 
longitudinal studies; charting perceived stigma pre- and post-diagnosis, as well as pre-and 
post-therapeutic intervention/treatment. Such studies would help develop a more 
comprehensive model of stigma in NEAD and how this may relate to future targeted 
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Appendix H: Liverpool Seizure Severity Scale – Revised (LSSS-3: Scott-Lennox, 


























Appendix I: histogram of standardised residuals  normal P-P plot of standardised 









Appendix J: histogram of standardised residuals  normal P-P plot of standardised residuals 










An analysis of standard residuals was carried out, which indicated that the data 
contained no outlier (NEAD: Std. Residual Min = -2.66, Std. Residual Max = 1.78; Epilepsy: 
Std. Residual Min = -1.74, Std. Residual Max = 2.046). 
 The data met the assumption of independent errors (NEAD: Durbin-Watson value = 
1.7; epilepsy: Durbin-Watson value = 1.44).  
To check if the data met the assumption of collinearity, test indicated that multi-
collinearity was not a concern (NEAD: PHQ9, Tolerance =.28, VIF = 3.54; GAD-7, 
Tolerance = .30, VIF = 3.33; GSE: Tolerance = .66, VIF= 1.5; LSSS = .94, VIF = 1.07, No. 
seizures per year, Tolerance = .95, VIF= 1.05; Epilepsy: PHQ9, Tolerance =.57, VIF = 1.76; 
GAD-7, Tolerance = .55, VIF = 1.81; GSE: Tolerance = .66, VIF= 1.5; LSSS = .87, VIF = 
1.15, No. seizures per year, Tolerance = .98, VIF= 1.01).  
The histogram of standardised residuals  for both NEAD (appendix I) and epilepsy 
(appendix J) indicated that the data had approximately normally distributed errors The normal 
P-P plot of standardised residuals for NEAD (appendix I) and epilepsy (appendix J) showed 
points that were clustered closely around the line. The scatterplot of standardised residuals for 
NEAD (appendix I) and epilepsy (appendix J)  indicated that the data met the assumptions of 
homogeneity of variance and linearity.  
The assumption of non-zero variances was also met (NEAD: PHQ-9, variance = 
62.54; GAD-7, variance = 43.7; GSE, variance = 44.82; SCCI-8, variance = 63.02; 
LSSS=71.07; Number of reported seizures per year, variance = 518091.65; Epilepsy: PHQ-9, 
variance = 42.1; GAD-7, variance = 47.11; GSE, variance = 73.01; SCCI-8, variance = 71.5; 
LSSS=71.5; Number of reported seizures per year, variance = 90454.43). 
